Same word, different job, No. 2: gate.
In a fund, a gate is a safety limit. When too many people ask for their money back at the same time, the fund can pay out only part of it and push the rest to the next payout date, so it doesn't have to sell everything in a hurry.
In @Morpho's newer vaults, a gate is an optional filter. It decides who can put money in, take money out or pass their share to someone else, for example after an identity check.
Morpho's docs are upfront that some gates can stop people from withdrawing. Setting one goes through the vault's own waiting period, and a vault can give up its gates for good.
So if a vault says it's gated, ask which way the gate swings.
Same word, different job: a short series on words that mean one thing in finance and something else onchain.
No. 1: allocator.
In finance, an allocator decides which fund managers get money. Think of a pension fund.
On @Morpho, an onchain lending network, people pool money in shared pots called vaults. There, the allocator is a job written into the code: it decides where the money gets lent out, but only to places the vault's risk manager has approved, and only up to set limits.
So if someone says "the allocator moved the money", ask which one.
This one is from another member @Theotime_EQUITY
Same word, different job: a short series on words that mean one thing in finance and something else onchain.
No. 1: allocator.
In finance, an allocator decides which fund managers get money. Think of a pension fund.
On @Morpho, an onchain lending network, people pool money in shared pots called vaults. There, the allocator is a job written into the code: it decides where the money gets lent out, but only to places the vault's risk manager has approved, and only up to set limits.
So if someone says "the allocator moved the money", ask which one.
wagti. retweeted
DeSci summer 🔥
Even @zacxbt , @phantom & @solana know it. 🧠
Maybe time to be interesting by my thesis about DeSci & @eterna_labs 👇
🧵DeSci Thesis
Eterna Labs is redefining how humanity approaches longevity research.
1- A broken system
Today, bringing a single therapeutic compound from discovery to market takes over ten years and costs billions. The process is centralized, slow, and opaque. As a result, progress in extending healthy human lifespan moves at a fraction of its potential speed.
2- Eterna Labs’ alternative
@eterna_labs is building a decentralized, open, and community-governed research protocol. All data related to funding, experimentation, and outcomes is coordinated and shared on-chain in real time. The goal is to dramatically accelerate the pace of scientific discovery, reduce costs, and make longevity research accessible to all.
3- The case for $RAP
The first compound launched by Eterna Labs is Rapamycin ($RAP), one of the most promising longevity drugs known to science. Originally approved as an immunosuppressant, Rapamycin has demonstrated the ability to significantly extend lifespan across multiple species including worms, flies, mice, and even primates.
Its mechanism of action targets the mTOR pathway, a master regulator of cellular growth and metabolism. By inhibiting mTOR, Rapamycin enhances autophagy, the body’s natural cellular cleanup process, removing dysfunctional components and delaying age-related decline.
This isn’t just theoretical. Rapamycin is already being used off-label in human anti-aging protocols, and a growing number of clinical trials are under way. The scientific consensus is clear: Rapamycin could be the most effective pharmacological intervention for delaying aging ever discovered.
4- From protocol to product
Unlike many compounds on Pump Science, which often exist only as speculative plays with no real-world
utility, Eterna Labs approached the launch of $RAP with a long-term vision.
The team established a direct partnership with a laboratory capable of synthesizing Rapamycin as a supplement.
This means the compound is not only being tested in worms and flies, but will also be accessible to the community for real-world, self-experimentation. Purchases made via the Eterna Labs affiliate link feed value directly back into the protocol: funding research, supporting operations, driving awareness, and eventually enabling DAO-led token buybacks.
5- $RAP: DeSci's leading compound
Within days of launch, $RAP became the top-ranked compound on Pump Science by market cap and traction. It has drawn the attention of strategic actors like Big Pharma, who acquired over 5% of the token supply.
6- Why now?
The « meme pad war » meta is showing signs of exhaustion. Meanwhile, DeSci is just beginning to break out, validated by Coinbase listing two major DeSci tokens ($RSC and $BIO) and by the massive performance of previous DeSci tokens like $URO and $RIF, which reached $250M and $150M in market cap respectively.
Eterna Labs is leading the second wave of DeSci with stronger fundamentals, real-world access, and early traction. With a clear vision, a compound backed by rigorous science, a growing treasury, and strong community and ecosystem support, Eterna Labs stands out as one of the most promising bets in the
space.
NFA-DYOR
Just my thesis, what are you thinks ?👇
wagti. retweeted
$DRUGS (@Big_Pharmai) x @eterna_labs partnership confirmed:
- Eterna is the team behind $RAP on @pumpdotscience
- Crossing the bridge between TradSci and DeSci
- They will use the BADDIE framework to assist in their research
- Big Pharmai now holds 1% of $PILL
This morning, we are welcoming @eterna_labs ( $PILL) as a partner.
Eterna is the team behind Rapamycin ( $RAP) on @pumpdotscience. Their goal is to cross the bridge between web3 and web2 science, bringing real novel treatments to Europe and beyond. They have worked on notable projects in the industry and are in this for the long run.
As they grow, they will be utilizing the BADDIE framework to assist in their research studying, discovering, and launching new drugs.
Big Pharmai now holds 1% of $PILL in our AUM.
Welcome, Eterna Labs!
wagti. retweeted
🧾 [Initiation File #ΞL-017]
Project: ETERNA – Strategic Partnership
Status: CONFIRMED
Partner: @Big_Pharmai
:: ENTRY 001 ::
AI Framework "BADDIE" integrated into Eterna Labs protocol.
Deployment objective:
Accelerate longevity research
Enhance experimental analysis
Amplify social outreach and community engagement
:: ENTRY 002 ::
Protocol leverage initiated.
AI-driven agents now operational within research, assistance, and communication pipelines.
Eterna Labs x Big Pharmai partnership online.
Human longevity meets artificial intelligence.
This morning, we are welcoming @eterna_labs ( $PILL) as a partner.
Eterna is the team behind Rapamycin ( $RAP) on @pumpdotscience. Their goal is to cross the bridge between web3 and web2 science, bringing real novel treatments to Europe and beyond. They have worked on notable projects in the industry and are in this for the long run.
As they grow, they will be utilizing the BADDIE framework to assist in their research studying, discovering, and launching new drugs.
Big Pharmai now holds 1% of $PILL in our AUM.
Welcome, Eterna Labs!
wagti. retweeted
[Log #011 - Protocol reserves (AUM) updated]
Initial value at DAO launch:
20 SOL (~$3,400)
Current value:
>$21,588
Note:
Reserve assets continue exponential growth.
Holdings secure. No unexpected transfers logged.
Data stream: highly positive.
Report transmission ongoing.
wagti. retweeted
[Log #009]
Protocol acquisition complete.
Assets secured:
- 6.3M $PILL tokens
- 15M $RAP tokens
• 8M via open market
• 7M via developer wallet transfer
Observation:
Eterna Labs now holds the largest position of $RAP.
Note to @Big_Pharmai : position #2 suits you well.
Data transmission continues.
wagti. retweeted
[Log #008]
Protocol reserves (AUM) updated.
Initial value at DAO launch:
20 SOL (~$3,400)
Current value:
>$9,000
Note:
An unexpected transfer of 1% $CAFF supply
has been logged from @caffeinepump.
These assets will be held securely within
the protocol reserves.
Data stream: positive.
Report transmission continues.
wagti. retweeted
🧾 [Initiation File #ΞL-013]
Compound: RAP – Rapamycin
Status: Trial deployment: ACTIVE
Location: @pumpdotscience
The first molecule of the Eterna protocol has been released.
From this moment:
– On-chain experimentation begins
– Data log in real-time
– Community-driven science, no gatekeepers
Capital flow is open.
Subjects who join this trial will become part of the first experiment in extending biological runtime.
Access: pump.science/experiments/RAP…
Report transmission has started.
7/And now, the big one.
Based on the public info from @pumpdotscience and the Eterna logs,
their first molecule – Rapamycin (RAP001) will be launched on Pump Science on 31/07.
1
1
126
8/Not financial advice.
But the concept, the narrative, the transparency… this one feels different.
Follow @EternaLabs and read the logs yourself.
104
wagti. retweeted
very thankful to @AbolishAging and @agelessrx_
with affiliate partnerships with established longevity companies, we will fuel onchain longevity markets
more to come
🧾 [Initiation File #ΞL-012]
Project: ETERNA – Partnership Deployment
Status: LIVE
Subject: @agelessrx_ x Eterna Labs
:: ENTRY 001 ::
The protocol expands.
Our first partnership connects the on-chain experiment with the real world.
:: ENTRY 002 ::
Eterna Labs is not only testing Rapamycin (RAP001) on-chain.
We are now taking it off-chain, giving every subject the ability to integrate it directly into their wellness routine.
:: ENTRY 003 ::
Through AgelessRx, a verified Eterna Labs affiliate link will allow you to order the same compound we are testing, closing the loop between research and application.
Each order flows back into the protocol:
– funding research
– rewarding the community
– fueling the DAO economy
:: ENTRY 004 ::
On-chain pharmacology becomes off-chain reality.
For the first time, subjects can take part in the experiment with their own biology.
The era of real-world DeSci begins.



















